The promoters of NGL Fine-Chem Limited have confirmed that they did not create any encumbrance, directly or indirectly, on the shares held by them in the company during the financial year ended March 31, 2026. This disclosure ensures that the shareholding of the promoters remains free from charges or pledges, which is critical for shareholder confidence regarding ownership stability. The confirmation was submitted to the company's Audit Committee in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The filing detailed the shareholding patterns of the promoters, members of the promoter group, and persons acting in concert as of March 31, 2026. The declaration was signed by Rajesh Lawande on behalf of the promoters, promoter group, and persons acting in concert. The document was addressed to the Audit Committee and the stock exchanges, BSE Limited and National Stock Exchange of India Limited, to ensure the information was placed on public record.

Promoter Shareholding Details

The disclosure provides a breakdown of the shares held by various promoter entities and individuals. The data highlights the concentration of ownership among key individuals and a corporate entity within the promoter group.

Rajesh Narayan Lawande holds the largest individual stake among the promoters with 1,352,366 shares, representing a 21.89% shareholding. Rahul Jayant Nachane follows with 1,083,450 shares, accounting for 17.54% of the total share capital. Other key stakeholders include Sunita Sandeep Potdar and Ajita Rahul Nachane, holding 13.38% and 11.55% respectively. PCI Ferrmone Chemicals India Private Limited holds 8.38% of the shares, while Pushpa Lawande holds no shares in the company.

NGL Fine-Chem Limited reported a strong financial performance for Q4 and FY26, driven by higher volumes and improved capacity utilization. Revenue from operations for Q4 FY26 stood at ₹149.23 crores, a 57% increase from ₹94.97 crores in Q4 FY25. Profit after tax for the quarter rose to ₹13.49 crores, compared to ₹0.54 crores in the corresponding period of the previous year. For the full fiscal year FY26, the company achieved a revenue of ₹500.95 crores, reflecting a 36% growth over FY25, while profit after tax grew by 128% to ₹48.13 crores.

The disclosure was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The earnings conference call was held on May 25, 2026, to discuss the operational and financial performance.

Financial Performance

The company reported significant margin expansion during the quarter. EBITDA for Q4 FY26 came in at ₹21.41 crores, compared to ₹6.32 crores in Q4 FY25, with an EBITDA margin of 14.35%. This represents an expansion of 769 basis points year-on-year. For the full year FY26, EBITDA stood at ₹72.69 crores, more than doubling from ₹33.87 crores in FY25, with a margin of 14.51%.

Operational Highlights

Management attributed the growth to higher volumes across the product portfolio and geographies. Animal API contributed 95% of the revenues during the quarter. The company noted that geopolitical developments led to increased freight costs and raw material prices, impacting margins sequentially. However, partial price pass-through was secured in the first quarter of the current financial year.

Capacity Expansion

Phase I of the expansion programme is operational and contributing to volumes. Phase II of the Greenfield expansion at Tarapur faced delays due to gas and labour shortages, with commissioning now scheduled for early Q2 FY27. Commercial production from Phase II is expected to commence in H2 FY27. The total planned capex for the expansion is ₹210 crores, of which ₹182.75 crores has been invested up to Q4 FY26.